Drug-induced pulmonary toxicity in a patient treated with mesalazine and azathioprine for ulcerative colitis

Acta Gastro-Enterologica Belgica

Volumn 70, Issue 3, 2007, Pages 290-292

  Katsenos, Stamatis ^a,c   Psathakis, Kostas ^a   Kokkonouzis, Ioannis ^a   Panagou, Panagiotis ^a   Tsintiris, Kostas ^a   Bouros, Demosthenes ^b  

^a KAT HOSPITAL   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MESALAZINE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG DOSE REDUCTION; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LOEFFLER PNEUMONIA; LUNG BIOPSY; LUNG LAVAGE; LUNG TOXICITY; MALE; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; ULCERATIVE COLITIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; BRONCHOALVEOLAR LAVAGE FLUID; COLITIS, ULCERATIVE; COUGH; DIARRHEA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOSUPPRESSIVE AGENTS; MALE; MESALAMINE; PULMONARY EOSINOPHILIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36048969835     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CAMUS P., PIARD F., ASHCROFT T., GAL A.A., COLBY T.V. The lung in inflammatory bowel disease. Medicine, 1993, 72 (3): 151-183.
2. TANIGAWA K., SUGIYAMA K., MATSUYAMA H. Mesalazine-induced eosinophilic pneumonia. Respiration, 1999, 66: 69-72.
3. BITTON A., PEPPERCON M.A., HANRAHAN J.P., UPTON M. Mesalamine-induced lung toxicity. Am. J. Gastroenterology, 1996, 91 (5): 1039-1040.
4. WELTE T., HAMM H., FABEL H. Mesalazine alveolitis. Lancet, 1991, 338: 1273.
5. ZEZOS P., MPOUMPONARIS A., KOUTSOPETRAS P., VOUNOTRYPIDIS P., MOLYVAS E., VADIKOLIAS K., MOSCHOS I., KOUKLAKIS G. Acute motor sensory polyneuropathy (AMSAN) complicating active ulcerative colitis with a patchy distribution. Acta Gastroenterol. Belg., 2007, 70 (2): 226-30.
6. VAN BIERVLIET S., RAES A., VANDE WALLE J., VAN WINCKEL M., ROBBERECHT E., PRAET M. Mesalazine interstitial nephritis presenting as colitis ulcerosa exacerbation. Acta Gastroenterol. Belg., 2006, 69(3): 321-2.
7. LAMERS C.B., GRIFFIOEN G., VAN HOQEZAND R.A., VEENENDAAL R.A. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease. Scand. J. Gastroenterol Suppl., 1999, 230: 111-115.
8. ARDIZZONE S., MACONI G., RUSSO A., IMBESI V., COLOMBO E., BIANCHI PORRO G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut, 2006, 55 (11): 47-53.
9. COOPER J.A. Jr., WHITE D.A., MATTHAY R.A. Drug-induced pulmonary disease: Part 1: Cytotoxic drugs. Part 2: Noncytotoxic drugs. Am. Rev. Respir. Dis., 1986, 133 321-340, 488-505.
10. ALLEN J.N., DAVIS W.B. State of the art: the eosinophilic lung diseases. Am. J. Respir. Crit. Care Med., 1994, 150: 1423-1438.
11. th edition. London: BC Decker, 2003: 485-534.
12. ALLEN J.N. Drug induced eosinophilic lung disease. Clin. Chest Med., 2004, 25: 77-88.
13. MAHADENA R., WALSH G., FLOWER C.D.R., SANDERSON J.M. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur. Respir. J., 2000, 15: 41-48.
14. TZANAKIS N., SAMIOU M., BOUROS D., MOUZAS J., KOUROUMALIS E., SIAFAKAS N.M. Small airways function in patients with inflammatory bowel disease. Am. J. Respir. Crit. Care Med., 1998, 157: 382-6.
15. www.pneumotox.com - Drug induced lung diseases. (Last update: Nov 13, 2006).
16. SALTZMAN K., ROSSOFF L.J., GOUDA H., TONGIA S. Mesalamine-induced unilateral eosinophilic pneumonia. AJR, 2001, 177: 257.
17. PEREZ C., ERRAZURIZ I., BROCKMANN P., GONZALEZ S., COFRE C. Eosinophilic pneumonia caused by mesalazine. Report of one case. Rev. Med. Chile, 2003, 131: 81-84.
18. DOSHI A.V., DESAI D., BHADURI A., UDWADIA Z.F. Lymphocytic interstitial pneumonitis associated with autoimmune hepatitis. Indian J. Gastroenterol., 2001, 20: 76-77.
19. REFABERT L., SINNASSAMY P., LEROY B., FAUROUX B., DE BLIC J., BENSMAN A. Azathioprine-induced pulmonary haemorrhage in a child after renal transplantation. Pediatr. Nephrol., 1995, 9: 470-473.
20. LIMPER A.H. Chemotherapy-induced lung disease. Clin. Chest Med., 2004, 25: 53-64.
21. HUNNINGHAKE G.W. Antioxidant therapy for idiopathic pulmonary fibrosis. N. Engl. J. Med., 2005, 353: 2285-2287.
22. COSTABEL U., UZASLAN E., GUZMAN J. Bronchoalveolar lavage in drug-induced lung disease. Clin. Chest Med., 2004, 25: 25-35.